Picture 1 of 5
Gallery
Picture 1 of 5
Have one to sell?
Molecular Cancer Therapeutics – Strategies for Drug Discovery and Development
US $139.99
ApproximatelyS$ 179.61
Condition:
“Marker on page (see photos.)”
Acceptable
A book with obvious wear. May have some damage to the cover but integrity still intact. The binding may be slightly damaged but integrity is still intact. Possible writing in margins, possible underlining and highlighting of text, but no missing pages or anything that would compromise the legibility or understanding of the text.
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Shipping:
US $21.20 (approx S$ 27.20) USPS Ground Advantage®.
Located in: Silver Spring, Maryland, United States
Delivery:
Estimated between Sat, 27 Sep and Wed, 1 Oct to 94104
Returns:
30 days return. Buyer pays for return shipping. If you use an eBay shipping label, it will be deducted from your refund amount.
Coverage:
Read item description or contact seller for details. See all detailsSee all details on coverage
(Not eligible for eBay purchase protection programmes)
Shop with confidence
Seller assumes all responsibility for this listing.
eBay item number:127058261921
Item specifics
- Condition
- Acceptable
- Seller Notes
- “Marker on page (see photos.)”
- Personalized
- No
- ISBN
- 9780471432029
About this product
Product Identifiers
Publisher
Wiley & Sons, Incorporated, John
ISBN-10
0471432024
ISBN-13
9780471432029
eBay Product ID (ePID)
5956053
Product Key Features
Number of Pages
368 Pages
Publication Name
Molecular Cancer Therapeutics : Strategies for Drug Discovery and Development
Language
English
Subject
Chemotherapy, Life Sciences / Biochemistry, Oncology, Pharmacology
Publication Year
2004
Type
Textbook
Subject Area
Science, Medical
Format
Hardcover
Dimensions
Item Height
0.9 in
Item Weight
29.3 Oz
Item Length
10.2 in
Item Width
7.3 in
Additional Product Features
Intended Audience
Scholarly & Professional
LCCN
2003-022153
Reviews
"...this little book represents the ever-so-important 'and' that links research and development together in a logical and thoughtful manner...a valuable resource for scientists and clinicians alike..." ( New England Journal of Medicine , January 27, 2005) "...an excellent publication.... I recommended it for libraries...those involved in cancer research...those who teach pharmacy and medical students about drugs used in the treatment of cancer." ( The Annals of Pharmacotherapy , December 2004) "...provides an up-to-date overview of the different phases of drug discovery and preclinical development of experimental cancer principles." ( Drug Discovery & Development , September 2004) "...a most informative book, discussing the important evolution in the field of cancer therapeutics..." ( American Journal of Therapeutics , July/August 2004)
Dewey Edition
22
Illustrated
Yes
Dewey Decimal
616.99/4061
Table Of Content
Preface. Contributors. Chapter 1. Introduction (G. Prendergast). Chapter 2. Molecular Cancer Therapeutics: Will the Promise Be Fulfilled? (B. Teicher). Chapter 3. Cancer Genetics and Drug Target Selection (G. Zhang & W. Kaelin). Chapter 4. RNA Interference in Mammals: Journey to the Center of Human Disease (P. Paddison & G. Hannon). Chapter 5. Applications and Issues for Tissue Arrays in Target and Drug Discovery (E. Jonasch, K. Do, C. Logothetis, & T. McDonnell). Chapter 6. Protein Transduction Strategies for Target and Mechanism Validation (S. Ezhevsky & S. Dowdy). Chapter 7. Drug Screening: Assay Development Issues (S. Carroll, J. Inglese, S. Mao, & D. Olson). Chapter 8. Gene Microarray Technologies for Cancer Drug Discovery and Development (R. te Poele, P. Clarke, & P. Workman). Chapter 9. Transgenic Mouse Models of Cancer (T. Bowen & A. Wynshaw-Boris). Chapter 10. Transgenic versus Xenograft Mouse Models of Cancer: Utility and Issues (M. Liu, W. Bishop, Y. Wang, & P. Kirschmeier). Chapter 11. Pharmacodynamic Assays in Cancer Drug Discovery: From Preclinical Validation to Clinical Trial Monitoring (R. Lobell, N. Kohl, & L. Sepp-Lorenzino). Chapter 12. Pharmacokinetic and Toxicology Issues in Cancer Drug Discovery and Development (P. Benfield & B. Car). Chapter 13. Clinical Development Issues (S. Averbuch, M. Wolf, B. El-Rayes, & P. LoRusso). Chapter 14. Intellectual Property and Commercialization Issues in Drug Discovery (L. Malseed). Index.
Synopsis
This invaluable reference promotes understanding of steps involved in developing drug leads for industrial partnering and development. It provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell- and molecule-based drug screening strategies, as well as mouse models for cancer., As cancer research increasingly becomes an applied science, academic and biotech researchers interested in general principles must think more about how their efforts translate into the clinical arena. At the same time, researchers on the industrial side stand to gain from a better understanding of the latest strategies for target and lead drug discovery. This way the great promise of new approaches to cancer drug development preventions and treatments that will be less toxic and more effective than current drugs through targeting specific molecular features of aberrant cells can finally be fulfilled. Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development offers an up-to-date overview of the different phases of drug discovery and preclinical development of new experimental cancer principles. In tying together the diverse set of disciplines and methods involved in these pursuits, the text covers: Discovery and validation of drug targets Drug screening Animal models Preclinical testing Pharmacology issues Clinical concerns Intellectual property issues Directed to a broad audience of students and professionals in academia and industry, Molecular Cancer Therapeutics provides a comprehensive summary of state-of-the-art strategies for identifying drug targets and developing lead inhibitors. With its coverage of target validation, drug screening, and pharmacokinetics, it is an invaluable reference for those working in oncology as well as the broad range of disciplines concerned with drug discovery and development., Molecular Cancer Therapeutics covers state-of-the-art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing. It provides a thorough treatment of drug target discovery, validation, and development. The introductory chapters provide an overview of pathways to discovery and development of molecular cancer therapeutics. Subsequent chapters progress from initial stages of drug target discovery to drug discovery, development, and testing in preclinical and clinical models. Topics include drug lead screening, drug-to-lead development, proof-of-concept studies, medicinal chemistry issues, intellectual property concerns, and clinical development. This invaluable reference promotes understanding of steps involved in developing drug leads for industrial partnering and development. It provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell- and molecule-based drug screening strategies, as well as mouse models for cancer. Coverage also includes how to refine drug leads for suitability in clinical testing, the special issues of clinical testing of molecular-targeted drugs, and intellectual property concerns.
LC Classification Number
RC271.C5M655 2004
Item description from the seller
Popular categories from this store
Seller feedback (11,618)
- Automatische feedback van eBay- Feedback left by buyer.Past monthBestelling voltooid - getrackt en op tijd
- Automatische feedback van eBay- Feedback left by buyer.Past monthBestelling voltooid - getrackt en op tijd
- Automatische feedback van eBay- Feedback left by buyer.Past monthBestelling voltooid - getrackt en op tijd